Current Research in Parasitology & Vector-Borne Diseases (CRPVBD) is a new primary research, gold open access journal from Elsevier. CRPVBD publishes Original Research articles, Short Communications, Letters, Opinion and Methodology articles as well as Reviews, Rapid Reviews and Graphical Reviews, that cover all aspects of human and animal parasitology and vector biology and vector-borne pathogens.
Current Research in Parasitology & Vector-Borne Diseases is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach, to ensure they are a widely read resource.
Current Research in Parasitology & Vector-Borne Diseases main research areas covered include (but are not restricted to):
Diversity, distribution, ecology, life cycles and transmission biology of parasites and arthropod vectors.
Identification, taxonomy, systematics and molecular phylogenetics of parasites and arthropod vectors.
Surveillance of indigenous and invasive arthropod vectors of public and veterinary health relevance: distribution, abundance and bionomics. Assessment of vector-pathogen relationships and the risk of pathogen transmission and associated disease.
Mathematical modelling of parasite and vector populations, parasitic infections, host-parasite and vector-pathogen interactions, and epidemiology of zoonotic and emerging/re-emerging infectious diseases.
Impact of environmental change on the transmission dynamics of parasites and the biology, ecology and distribution of intermediate hosts and vectors. Emergence, re(emergence) and globalisation of vectors, pathogens and hosts and One Health.
Parasitic and vector-borne diseases of humans, wildlife and domestic, farm and companion animals including studies on immunology, immunopathology, diagnosis and control.
Neglected tropical diseases (NTDs): diagnosis, monitoring, control and eradication/elimination. Model-based analyses addressing the transmission dynamics and control of Chagas disease, visceral leishmaniasis, human African trypanosomiasis, soil-transmitted helminths, schistosomiasis, lymphatic filariasis, onchocerciasis and trachoma.
Molecular aspects of parasite and vector diversity and evolution including molecular epidemiology and population genetics mechanisms of anti-parasite drug resistance and insecticide resistance in arthropod vectors.
Use of genomics, proteomics and bioinformatics technologies to study host-parasite/pathogen and parasite-host-microbiota interactions, and pathogen-microbiome interaction in vectors.
Economic impact assessments of parasitic infections or vector-borne diseases.
Outbreak investigations and impact assessments.
Topics which may be considered for the journal only if the following requirements are met:
Studies assessing prevalence rates of parasites and pathogens in arthropod vectors (ticks, mosquitoes, sand flies) that are not restricted to local or small regional scales and address gaps in large-scale temporal and/or spatial patterns of host-parasite and arthropod-pathogen systems.
Major reviews of the systematics and taxonomy of parasites and arthropod vectors that provide a novel background in the field.
Assessment of novel chemicals (attractants, adulticides of larvicides) if at an advanced stage with extensive laboratory data and chemical analysis to characterize active ingredients and field data on efficacy and biosafety.
Clinical trial studies if these include mechanistic insight into intervention efficacy from parasitology and/or vector data.
Current Research in Parasitology & Vector-Borne Diseases builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.
Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.
Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.
Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.
Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing.
For more information, please refer to: https://www.elsevier.com/conflictsofinterest
Current Research in Virological Science is being discontinued as of June 2022. If you are interested in submitting your paper to a journal please consider:
Current Research in Microbial Sciences, at: https://www.journals.elsevier.com/current-research-in-microbial-sciences
Current Research in Immunology, at: https://www.journals.elsevier.com/current-research-in-immunology
We would like to express our sincere thanks to the authors, reviewers and editorial board who contributed to the journal over the past years.
Published papers will remain available on ScienceDirect at: https://www.sciencedirect.com/journal/current-research-in-virological-science
Current Research in Virological Science (CRVIRO) is a new primary research, gold open access journal from Elsevier. CRVIRO publishes original papers, reviews, graphical reviews, follow-up manuscripts, and short communications resulting from research in virology.
Current Research in Virological Science is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Virology (2020 Journal Impact Factor 7.090, CiteScore 10.6) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.
Current Research in Virological Science publishes studies on all aspects of animal, plant, bacterial and human viruses. The journal welcomes articles on the full range of topics in virology, from basic biochemical, molecular and cell biological studies to clinically relevant translatable and translational studies. Topics covered include Emerging viruses: Interspecies transmission; Viral immunology; Viral pathogenesis; Preventive and therapeutic vaccines; Antiviral strategies; Virus structure and expression; Animal models for viral diseases; Engineering for viral resistance; Viruses and cancer; Virus vector interactions.
Current Research in Virological Science builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.
Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.
Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.
Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.
Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing.
For more information, please refer to https://www.elsevier.com/conflictsofinterest
Decoding Infection and Transmission is a gold open access, peer-reviewed journal. It is dedicated to the rapid publication and global dissemination of the latest research findings about the characteristics and mechanisms of pathogenic infections and disease transmission. All analyses and use of data resources relating to infectious diseases are welcome, including epidemiological data, omics data and biological functional data. The journal aims to bridge the gap between research scientists, clinical physicians, public health professionals and veterinarians working in diverse infectious diseases.
Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.
Diagnostic Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, immunology, immunoserology.
Submissions on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.
The journal publishes topics including:
Informed commentaries on new antibiotics
Rapid and cost-effective methods in the laboratory
Instructive case studies with emphasis on complex circumstances
Insightful editorials on important current issues
Book reviews that keep you up-to-date on recently published literature
Laboratory and clinical management of microbial diseases
Epidemiology and pathogenesis of infections
Automation in the diagnostic microbiology laboratory
Antibiotic susceptibility testing
Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
An Official Journal of Shandong University
Engineering Microbiology is a peer reviewed, open access journal. All Article Publishing Charge (APC) fees for accepted articles will be covered. In addition, any required language editing fees will be covered for all accepted articles.
Engineering Microbiology is dedicated to publishing rigorously peer-reviewed, high-quality original research papers that make significant, important, and novel contribution in the methodology, theory, mechanism, and application of engineering microbes (archaea, bacteria, eukaryotic microbes, viruses) with an ultimate goal of improving microbes for practical applications. Papers describing the improvement of microbial communities and microbial cellular and biochemical components (such as enzymes) are also welcome. Papers describing fundamental microbial biology that do not see an eventual application potential are not in the scope of the journal.
Engineering Microbiology covers fields including but not limited to:
Microbial methodology and technology
Microbial cell engineering
Genetic engineering
Metabolic engineering
Enzyme engineering
Microbial synthetic biology
Microbial engineering for natural products and bulk/fine chemicals
Medical and pharmaceutical microbiology and biotechnology
Microbiota engineering
Environmental microbial engineering
Microbial genome editing technology
Engineering of microbial regulatory networks
Theories for microbial engineering
Bioinformatics and computational analysis of microbial engineering
Biotechnology Research and Reviews
Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.
We especially encourage submissions on:
Biocatalysis and the use of Directed Evolution in Synthetic Biology and Biotechnology
Biotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and Biofuels
New Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems Biology
New Biotechnological Approaches in Genomics, Proteomics and Metabolomics
Metabolic Engineering, Biomolecular Engineering and Nanobiotechnology
Manuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.
The Journal on Infectious Disease Dynamics
Epidemics publishes papers on infectious disease dynamics in the broadest sense. Its scope covers both within-host dynamics of infectious agents and dynamics at the population level, particularly the interaction between the two. Areas of emphasis include: spread, transmission, persistence, implications and population dynamics of infectious diseases; population and public health as well as policy aspects of control and prevention; dynamics at the individual level; interaction with the environment, ecology and evolution of infectious diseases, as well as population genetics of infectious agents.The journal will only publish papers that use high quality novel or published data in their analysis. Successful manuscripts are typically multidisciplinary and integrative. Methodological manuscripts are only acceptable if they present a clear and relevant biological application for which novel insight is gained.
Articles deal with protists, unicellular organisms encountered free-living in
various habitats or as parasites or used in basic research or applications. The
European Journal of Protistology covers topics such as the structure and systematics
of protists, their development, ecology, molecular biology and physiology. Beside
publishing original articles the journal offers a forum for announcing scientific
meetings. Reviews of recently published books are included as well. With its diversity
of topics, the European Journal of Protistology is an essential source of information
for every active protistologist and for biologists of various fields.
Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center